Showing 1 - 4 results of 4 for search 'Pavlu, J', query time: 1.46s
Refine Results
-
1
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy by Loke, J, Metzner, M, Boucher, R, Jackson, A, Hopkins, L, Pavlu, J, Tholouli, E, Drummond, M, Peniket, A, Bishop, R, Fox, S, Vyas, P, Craddock, C
Published 2021Journal article -
2
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. by Chaidos, A, Patterson, S, Szydlo, R, Chaudhry, M, Dazzi, F, Kanfer, E, McDonald, D, Marin, D, Milojkovic, D, Pavlu, J, Davis, J, Rahemtulla, A, Rezvani, K, Goldman, J, Roberts, I, Apperley, J, Karadimitris, A
Published 2012Journal article -
3
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT. by Innes, A, Beattie, R, Sergeant, R, Damaj, D, Foroni, L, Marin, D, Kanfer, E, Mielke, S, Milojkovic, D, MacDonald, D, Pavlu, J, Rahemtulla, A, Roberts, I, Slade, D, Bray, E, Goldman, J, Apperley, J, Szydlo, R, Dazzi, F, Rezvani, K
Published 2013Journal article -
4
Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia by Craddock, C, Jackson, A, Loke, J, Siddique, S, Hodgkinson, A, Mason, J, Andrew, G, Nagra, S, Malladi, R, Peniket, A, Gilleece, M, Salim, R, Tholouli, E, Potter, V, Crawley, C, Wheatley, K, Protheroe, R, Vyas, P, Hunter, A, Parker, A, Wilson, K, Pavlu, J, Byrne, J, Dillon, R, Khan, N, McCarthy, N, Freeman, SD
Published 2020Journal article